Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LEXX, LEXXW | Lexaria Bioscience Corp. | Chief Executive Officer | $124K | +$118K | +2269% | Dec 2, 2024 |
NVIV | INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Financial Officer | Nov 17, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|